Alembic Pharmaceuticals Ltd has received an Establishment Inspection Report (EIR) from the US Food and Drug Administration (USFDA) for its solid oral formulation facility (F-4) at Jarod, Vadodara. The inspection was conducted between November 14-22, 2024, and the facility has been classified under “Voluntary Action Indicated” (VAI). What Does It Mean? A VAI classification indicates …